EP3519422
C7 SUBSTITUTED OXYSTEROLS AND THESE COMPOUNDS FOR USE AS NMDA MODULATORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.9.2017EP published:
31.8.2022EP application number:
17784770.4
EPO information:
European Patent Register
Max expiry date:
29.9.2037
Title in English:
C7 SUBSTITUTED OXYSTEROLS AND THESE COMPOUNDS FOR USE AS NMDA MODULATORSLanguage of the patent:
English
Timeline
Today
30.9.2017EP application
31.8.2022EP Publication
Owner
Name:
Sage Therapeutics, Inc.Address:
215 First Street, Cambridge, MA 02142, US
Inventor
Name:
SALITURO, Francesco, G.Address:
Marlborough, MA 01752, US
Name:
ROBICHAUD, Albert, J.Address:
Cambridge, MA 02141, US
Name:
MARTINEZ BOTELLA, GabrielAddress:
Wayland, MA 01778, US
Name:
GRIFFIN, AndrewAddress:
L'Ile Bizard, Quebec H9C 2Y, CA
Name:
HARRISON, Boyd, L.Address:
Princeton Junction, NJ 08550, US
Name:
LA, DanielAddress:
Cambridge, MA 02142, US
Priority
Number:
201662402789 PDate:
30.9.2016Country:
US
Number:
201662402797 PDate:
30.9.2016Country:
US
Classification
Categories:
C07J 9/00, C07J 41/00, C07J 31/00, C07J 7/00, A61P 25/00, A61K 31/575, A61P 1/00, A61P 1/04, A61P 1/10, A61P 3/00, A61P 3/10, A61P 9/14, A61P 17/06, A61P 19/02, A61P 19/08, A61P 23/00, A61P 25/04, A61P 25/08, A61P 25/14, A61P 37/06, A61P 35/00, A61P 25/18, A61P 25/20, A61P 25/22, A61P 25/24, A61P 25/28, A61P 25/30, A61P 27/16, A61P 29/00, A61P 25/16